Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Sep 1;28(9):e126-e127.
doi: 10.1093/ibd/izac005.

SARS-CoV-2 Infection in the Follow-Up of a Population With Inflammatory Bowel Disease

Affiliations
Editorial

SARS-CoV-2 Infection in the Follow-Up of a Population With Inflammatory Bowel Disease

Rodrigo Quera et al. Inflamm Bowel Dis. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Tripathi K, Godoy Brewer G, Nguyen MT, et al. . COVID-19 and outcomes in patients with inflammatory bowel disease: systematic review and meta-analysis. Inflamm Bowel Dis. 2021; XXX:XXX–XXX. doi:10.1093/ibd/izab236. - DOI - PMC - PubMed
    1. Gilissen LPL, Heinen SGH, Rijpma-Jacobs L, et al. . Neither inflammatory bowel disease nor immunosuppressants are associated with an increased risk of severe COVID-19: an observational Dutch cohort study. Clin Exp Med. Published online September 20, 2021. doi:10.1007/s10238-021-00755-3 - DOI - PMC - PubMed
    1. Singh AK, Jena A, Kumar-M P, et al. . Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. United European Gastroenterol J. 2021;9:159-176. - PMC - PubMed
    1. Kennedy NA, Lin S, Goodhand JR, et al. .; Contributors to the CLARITY IBD study. Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD. Gut. 2021;70:1884-1893. - PubMed
    1. Doherty J, Fennessy S, Stack R, et al. . Review Article: vaccination for patients with inflammatory bowel disease during the COVID-19 pandemic. Aliment Pharmacol Ther. 2021;54:1110-1123. - PMC - PubMed